Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Sixty-seven percent of healthcare system leaders are “very or extremely” concerned about Medicaid and Medicare reimbursement impacts and potential disruption to hospital operations, with 61% expect | If potential reimbursement cuts exceed 10%, respondents say it will have negative impacts on staffing decisions and technological investments.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Hospitals on the Edge: A Time for CMS to Do No Harm | The Centers for Medicare & Medicaid Services' job is to implement last…

The Trump administration is proposing sweeping changes to Medicare payment and value-based care programs it says will expand…

Healthcare affordability remains at the top of voters’ minds for the upcoming 2026 midterm elections, though fraud discussions…

The Trump administration proposed major changes to Medicare payment policies that will block third-party vendors from remote…

The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers…

The Centers for Medicare and Medicaid Services’ recent proposal to overhaul Medicare’s reimbursement rates for 340B drugs will be…